Latest Breaking News On - Lifeline ventures - Page 1 : comparemela.com

TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024

Maria 01 rolls out ambitious pan-Europe startup plan

Finnish startups face funding dip, but domestic venture capital flourishes amid economic uncertainty

In 2023, Finnish startups experienced a significant reduction in funding, down from the previous year s record highs, reflecting a broader trend of economic slowdown affecting startup investments across Europe and the United States. According to the Finnish Venture Capital Association (FVCA), total growth funding for Finnish startups was approximately €871 million, a sharp decline from the €1.7 billion raised in 2022.

TILT Biotherapeutics Presents Clinical Data on TILT-123 in Combination with KEYTRUDA® (pembrolizumab) for Ovarian Cancer at AACR 2024

Results Reveal Mechanism of Action and Correlative Analyses DataHELSINKI, Finland, April 10, 2024 (GLOBE NEWSWIRE) TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies presented promising preliminary safety and efficacy data from their ongoing Phase I clinical trial (NCT05271318) in platinum resistant or refractory ovarian cancer patients at the American Association for Cancer Research (AACR) Annual Meeting 2024. TILT-123 in combination with MS

The hottest of Helsinki - 10 startups to watch out this year

Helsinki is one of the hottest startup hubs in the world, growing numerous successful startups to watch out for in 2024.